TP53 and breast cancer: In mutant p53-breast cancer cell lines MDA-MB-231 and T-47D, PTS facilitated the reduction in oncogenic β-catenin, mTOR, and mutant p53, as well as increased the expression of the pro-apoptotic Bax protein [87].